已核实 DOI PubMed 相关产品: 1

A polysaccharide from Gynostemma pentaphyllum: structure characterization and anti-insulin resistance potential through Galectin-3 modulation

Journal 2025 · IF 8.5 · 发表于 2025 年 4 月 28 日
作者: Mingwang Ren,Guoqing Sun,Xiaoyu Ding,Xiaolin Yu,Li He,Shiji Xiao,Minjian Dong,Jianwen Yang,Kan Ding,Chengxin Sun
阅读全文 在 PubMed 查看

摘要

Polysaccharides are among the key bioactive components of Gynostemma pentaphyllum (Thunb.) Makino . In this study, a novel polysaccharide fraction, GPPA1-1, was isolated from G. pentaphyllum and purified using DEAE-Sepharose Fast Flow, Sephadex G-75, and Sepharose CL-6B column chromatography. GPPA1-1 was determined to have a molecular weight of 3.7 × 10 4  Da and was composed of mannose (Man), glucuronic acid (GlcA), rhamnose (Rha), glucose (Glc), galactose (Gal), and arabinose (Ara) in a molar ratio of 3.88:3.97:21.77:7.02:45.65:17.71. Comprehensive structural characterization was conducted using Congo red staining, FT-IR spectroscopy, Methylation analysis, and NMR analysis. The backbone of GPPA1-1 was identified as comprising →4)-α-Gal p- (1→, →4)-α-Gal p- (3,1→, →2)-α-Rha p- (4,1→, and →2)-α-Rha p- (1→, with branch chains containing α-Ara f -(1→, →5)-α-Ara f -(1→, →3)-α-Galp-(1→, and -α-GlcA-(1→. Biological assays demonstrated that GPPA1-1 effectively alleviates insulin resistance by inhibiting Galectin-3. This activity was confirmed through various experiments, including Galectin-3-mediated hemagglutination, Western blotting, CETSA, and glucose uptake assays. These findings highlight the potential of GPPA1-1 as a promising therapeutic agent for managing insulin resistance.

本研究中使用的阿拉丁产品

1 款产品在本文中被引用